| Description |
1 online resource |
| Series |
RSC drug discovery ; 38 |
|
RSC drug discovery series ; 38
|
| Contents |
Htl-9781849738064.pdf -- foreword-9781849738064.pdf -- Foreword -- Foreword -- preface-9781849738064.pdf -- Preface -- toc-9781849738064.pdf -- Contents -- CH01-9781849738064.pdf -- Part1.pdf -- What are Rare Diseases and Orphan Drugs? -- CH01-9781849738064.pdf -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 |
|
Chapter 1Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- Chapter 1 -- CH02-9781849738064.pdf -- Part2.pdf -- Screening, Diagnosis and Basic Science -- CH02-9781849738064.pdf -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- Chapter 2 -- CH03-9781849738064.pdf -- Part3.pdf -- Drug Development Factors -- CH03-9781849738064.pdf -- Chapter 3 -- Chapter 3 -- Chapter 3 |
|
Chapter 3Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- Chapter 3 -- CH04-9781849738064.pdf -- Part4.pdf -- Commercial Considerations -- CH04-9781849738064.pdf -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 |
|
Chapter 4Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- Chapter 4 -- CH05-9781849738064.pdf -- Part5.pdf -- The Role of Advocacy -- CH05-9781849738064.pdf -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 |
|
Chapter 5Chapter 5 -- Chapter 5 -- Chapter 5 -- Chapter 5 -- CH06-9781849738064.pdf -- Part6.pdf -- Lysosomal Storage Disorders -- CH06-9781849738064.pdf -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- Chapter 6 -- CH07-9781849738064.pdf -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 -- Chapter 7 |
| Bibliography |
Includes bibliographical references at the end of each chapters and index |
| Notes |
English |
|
Print version record |
| Subject |
Orphan drugs.
|
|
Rare diseases -- Treatment
|
|
Therapeutics.
|
|
Pharmaceutical industry.
|
|
Industries.
|
|
Diseases.
|
|
Chemotherapy.
|
|
Therapeutics
|
|
Disease Attributes
|
|
Drug Industry
|
|
Industry
|
|
Pathologic Processes
|
|
Analytical, Diagnostic and Therapeutic Techniques and Equipment
|
|
Pathological Conditions, Signs and Symptoms
|
|
Technology, Industry, and Agriculture
|
|
Disease
|
|
Technology, Industry, Agriculture
|
|
Rare Diseases
|
|
Drug Therapy
|
|
Orphan Drug Production
|
|
industries (organizations)
|
|
industry (economic concept)
|
|
illness.
|
|
disease.
|
|
Pharmacology.
|
|
MEDICAL -- Pharmacology.
|
|
Orphan drugs.
|
|
Médicaments orphelins.
|
| Form |
Electronic book
|
| Author |
Pryde, David C
|
|
Palmer, Michael J
|
|
Royal Society of Chemistry (Great Britain)
|
| ISBN |
9781782624202 |
|
1782624201 |
|
1849738068 |
|
9781849738064 |
|
